|
|||||||||||||||||
|
EID
Home | Ahead of Print | Past
Issues | EID Search | Contact
Us | Announcements | Suggested
Citation | Submit Manuscript
Volume 11, Number 6, June 2005 Integrating Escherichia coli Antimicrobial Susceptibility Data from Multiple Surveillance ProgramsJohn M. Stelling,*† Karin Travers,* Ronald N. Jones,‡§ Philip J. Turner,¶
Thomas F. O'Brien,*† and Stuart B. Levy*§ |
||
|
Back to article | |
Figure 3. SENTRY results for antimicrobial agents tested in common with MYSTIC. Annual nonsusceptibility rates of Escherichia coli, 1997–2001. p<0.05. CAZ, ceftazidime; TZP, piperacillin/tazobactam; GEN, gentamicin; CIP, ciprofloxacin; TOB, tobramycin; FEP, cefepime. |
|
|
|
EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z |
|
This page last reviewed May 18, 2005 |
|
Emerging
Infectious Diseases Journal |
|